Advertisements



We are Sorry, This Page doesn't Exist


Thermo Fisher to buy Dutch company in $11.5B deal

The most valuable company headquartered in Massachusetts, Thermo Fisher Scientific Inc., plans to get even larger through the acquisition of a Dutch maker of molecular diagnostics in a deal worth $11.5 billion. Waltham-based Thermo Fisher (NYSE: TMO) sai.....»»

Category: topSource: bizjournalsMar 3rd, 2020

GenMark Diagnostics Reports Fourth Quarter and Full Year 2019 Results

CARLSBAD, Calif., March 02, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced financial results for the fourth quarter and year ende.....»»

Category: earningsSource: benzingaMar 2nd, 2020

Co-Diagnostics stock soars 57% on high hopes for its coronavirus test

Shares of Co-Diagnostics Inc. , a molecular diagnostics company that.....»»

Category: topSource: marketwatchFeb 27th, 2020

Hedge Fund and Insider Trading News: Paul Singer, Stephen Mandel, Meritage Homes Corp (MTH), Alta Equipment Group Inc (ALTG), and More

UPDATE 2-Activist Hedge Fund Elliott Builds Stake in Dutch Insurer NN Group (Reuters) AMSTERDAM, Feb 20 (Reuters) – Elliott Investment .....»»

Category: topSource: insidermonkeyFeb 20th, 2020

Coronavirus update: Vaccine stocks retreat and airport screening expands to 20 U.S. airports

A nearly weeklong rally for vaccine and diagnostics developers looking to capitalize on the coronavirus outbreak ended on Tuesday......»»

Category: topSource: marketwatchJan 28th, 2020

Co-Diagnostics" stock tumbles after stock sale agreement priced at 29% discount

Shares of Co-Diagnostics Inc. tumbled 16% in premarket trading Friday, after the molecular diagnostics company took advantage of the prior session's big .....»»

Category: topSource: marketwatchJan 24th, 2020

Co-Diagnostics Rallies On Plans To Develop Screening Test For Coronavirus

Shares of molecular diagnostic company Co-Diagnostics Inc (NASDAQ: CODX) are riding high on the Wuhan coronavirus wave, at their highest level in about a year. 0 read more.....»»

Category: blogSource: benzingaJan 23rd, 2020

World"s largest asset manager gets tough on climate change

BLACKROCK-FINK/ (UPDATE 4, PIX):UPDATE 4-BlackRock takes tougher stance on climate after activist heat.....»»

Category: topSource: moneycentralJan 14th, 2020

Myriad Genetics"s stock surges after FDA approval of diagnostic test for pancreatic cancer

Share of Myriad Genetics Inc. shot up 8.3% in premarket trading Monday, after the molecular diagnostics company said its BRACAnalysis CDx was approved by the Food and Drug Administration as a companion test to iden.....»»

Category: topSource: marketwatchDec 30th, 2019

$50M deal could expand NanoString Technologies diagnostic test into more markets

NanoString, which creates devices for molecular diagnostics and research tools to understand diseases and develop drugs, will record more than $100 million in revenue this year......»»

Category: topSource: bizjournalsDec 3rd, 2019

Sense Biodetection Raises $15.8m to Develop Diagnostics Tests

Cambridge, UK-based Sense Biodetection—or Sense—has raised a $15.8 million Series A funding round, as it scales out its portfolio of molecular diagnostics products. The round, led .....»»

Category: topSource: redherringOct 29th, 2019

OpGen To Merge With German Molecular Diagnostics Company Curetis In $24M Deal

In a health care deal announced Wednesday, OpGen Inc (NASDAQ: OPGN) said it will acquire German molecular diagnostics company Curetis. read more.....»»

Category: blogSource: benzingaSep 4th, 2019

Diagnostics Startup Atonarp Wins $33m Series C Round

Tokyo-based Atonarp, a high-molecular diagnostics firm, has raised $33 milli.....»»

Category: topSource: redherringAug 26th, 2019

MDxHealth (R): MDxHealth Announces Favorable Draft Medicare Coverage for the SelectMDx Test

IRVINE, CA – August 26, 2019 – MDxHealth SA (Euronext: MDXH.BR), a commercial-stage innovative molecular diagnostics company, today announced tha.....»»

Category: earningsSource: benzingaAug 26th, 2019

Co-Diagnostics, Inc Reports Quarter on Quarter Sales Growth for Q2 2019

Salt Lake City, UT, Aug. 14, 2019 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. (NASDAQ:CODX), a molecular diagnostics company with .....»»

Category: earningsSource: benzingaAug 14th, 2019

Exact Sciences to combine with Genomic Health in cash and stock deal valued at $2.8 billion

Molecular diagnostics company Exact Sciences Corp. and Genomic Health Inc......»»

Category: topSource: marketwatchJul 29th, 2019

What Caused The Opening Gap In Co-Diagnostics?

For real-time updates on CODX, beat the news and login or try Benzinga Pro. Provider of molecular tools for detection of infectious diseases, Co-Diagnostics (NYSE: CODX) today had a large opening gap of 52.39%. read more.....»»

Category: blogSource: benzingaJul 18th, 2019

Mid-Afternoon Market Update: EXFO Falls On Downbeat Q3 Results; Co-Diagnostics Shares Surge

Toward the end of trading Thursday, the Dow traded up 0.51% to 26,996.63 while the NASDAQ fell 0.24% to 8,183.09. The S&P also fell, dropping 0.06% to 2,991.27. Leading and Lagging Sectors read more.....»»

Category: blogSource: benzingaJul 11th, 2019

Interpace Diagnostics" molecular thyroid cancer tests covered by Independence

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 20th, 2019

Cancer Diagnostic Company Biocept"s Stock Doubles In Value: What You Need To Know

Shares of Biocept Inc (NASDAQ: BIOC), a molecular diagnostics company specializing in biomarker analysis of circulating tumor-associated DNA, are making a strong read more.....»»

Category: blogSource: benzingaMay 20th, 2019